Cigna Shares Slip After Beat-and-Raise; Cost Pressures and Insider Sales Temper Gains
Cigna reported second-quarter adjusted EPS of $7.78 and revenue of $71.7 billion, both above Wall Street estimates, and nudged its 2026 adjusted EPS outlook to at least $30.45. Despite the beat-and-raise, shares slipped about 1.0% in pre-market trading as rising medical costs, declining medical customer counts, a leadership transition and recent in…